Status:
COMPLETED
Intrauterine G-CSF Administration in RIF
Lead Sponsor:
Gurgan Clinic
Conditions:
Infertility
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
Aim of this study is to investigate the effects of intrauterine G-CSF on endometrial thickness, clinical pregnancy rate and live birth rate in a recurrent implantation failure (RIF) group
Detailed Description
This study was designed as a prospective randomized controlled trial with the involvement of 200 RIF group patients.The procedure will perform by administering 30 mIU of Leucostim®(Filgrastim \[G-CSF\...
Eligibility Criteria
Inclusion
- Women under the age of 40 who met the RIF definition
- Follicle-stimulating hormone (FSH) levels were \<15 IU/mL
Exclusion
- Patients with congenital uterine anomalies
- Patients with Asherman's syndrome
- Patients with uterine cavity distorted by myoma or endometrial polyps
- Patients with confirmed endometriosis or endometrioma
- Patients for whom G-CSF was contraindicated (active infections, kidney disease, sickle cell anemia, malignancies, chronic neutropenia)
Key Trial Info
Start Date :
November 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2018
Estimated Enrollment :
157 Patients enrolled
Trial Details
Trial ID
NCT03783208
Start Date
November 1 2018
End Date
December 20 2018
Last Update
December 24 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gurgan Clinic IVF and Women Health Center
Ankara, Cankaya, Turkey (Türkiye), 06640